Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
UTD2 is the world's first oral epothilone microtubule inhibitor
The product is expected to be launched in June 2023
This is the second US FDA GMP inspection of this facility within one year
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Subscribe To Our Newsletter & Stay Updated
